✦ LIBER ✦

Bioavailability of Extended-Release Nevirapine 400 and 300 mg in HIV-1: A Multicenter, Open-Label Study

✍ Scribed by Manuel Battegay; Keikawus Arasteh; Andreas Plettenberg; Johannes R. Bogner; Jean-Michel Livrozet; Mallory D. Witt; Erik Mossdorf; Chan-Loi Yong; Wei Zhang; Sreeraj Macha; Frank Berger; Jerry Stern; Patrick Robinson; Anne-Marie Quinson

Book ID: 113544462
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 343 KB
Volume: 33
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2011.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twenty-four-week efficacy and safety of

Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)

✍ K Arasteh; D Ward; A Plettenberg; JM Livrozet; C Orkin; C Cordes; J Guo; E Wang; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Efficacy of solifenacin in patients prev

Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study

✍ Michael B. Chancellor; Norman Zinner; Kristene Whitmore; Kathleen Kobashi; Jeffr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A phase i, randomized, open-label, cross

A phase i, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults

✍ Dennis Swearingen; Michael Pennick; Amir Shojaei; Andrew Lyne; Kimberly Fiske 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 726 KB

Relative bioavailability of two formulat

Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states

✍ José Homero de Souza Filho; Felipe Nunes Bonifácio; Danilo César Galindo Bedor; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Effects of fluvastatin extended-release

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: A 12-week, multicenter, randomized, open-label, parallel-group study

✍ Luis A. Alvarez-Sala; Victoria Cachofeiro; Luis Masana; Carmen Suarez; Blanca Pi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Effectiveness, pharmacokinetics, and saf

Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study

✍ Michael Marberger; Amir V Kaisary; Neal D. Shore; Gary S. Karlin; Claudio Savuls 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB